Efficacy and safety of Busulfan–Fludarabine versus Busulfan–Cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplant in hematologic malignancy patients: a meta-analysis of randomized controlled trials and observational studies

Aizaz Ali, Muhammad Abdullah Ali, Abdullah Afridi, Hammad Ali, Umair Ul Haq, Muhammad Osama, Muhammad Umar Afridi, Touba Azeem, Mian Aban Masaud, Fazia Khattak, Fiza Safeer, Areeba Khan, Muhammad Sufyan Darwesh, Nimra Ehsan, Wahab Zia, Gulmeena Riffat, Abdul Moeez, Kamil Ahmad Kamil

Therapeutic Advances in Hematology

Published online on January 17, 2026

Abstract

Therapeutic Advances in Hematology, Volume 17, January-December 2026.
Background:Conditioning regimen selection significantly impacts the outcomes of allogeneic hematopoietic stem cell transplantation (HSCT) in patients with hematologic malignancies. However, comparative evidence between Busulfan–Fludarabine and Busulfan–...